Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Petrie

Showing results (291-300 of 557) with videos related to

Pageof 56
Sort By:
European Heart Journal|January 29, 2024
A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy RegistryAlice M Jackson, Sorel Goland, Hasan Ali Farhan, et al.
The Lancet. Healthy Longevity|September 21, 2023
Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide studyMariam Elmegaard Malik, Jawad Haider Butt, Jarl Emanuel Strange, et al.
European Heart Journal|April 17, 2008
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programmeMichael R MacDonald, Mark C Petrie, Fumi Varyani, et al.
European Heart Journal|March 6, 2025
Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysisMatthew Ryan, Mark C Petrie, Evangelos Kontopantelis, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 21, 2020
Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysisMario Gaudino, Irbaz Hameed, Faiza M Khan, et al.
Journal of the American Heart Association|September 29, 2022
Adherence and Discontinuation of Optimal Heart Failure Therapies According to Age: A Danish Nationwide StudyCaroline H Garred, Deewa Zahir, Jawad H Butt, et al.
Lancet (London, England)|March 31, 2016
A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trialGerd Hasenfuß, Chris Hayward, Dan Burkhoff, et al.
Heart (British Cardiac Society)|August 10, 2016
Infarct size and left ventricular remodelling after preventive percutaneous coronary interventionKenneth Mangion, David Carrick, Barry W Hennigan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 4, 2020
Thermodilution-derived temperature recovery time: a novel predictor of microvascular reperfusion and prognosis after myocardial infarctionAnnette M Maznyczka, David Carrick, Keith G Oldroyd, et al.
ESC Heart Failure|December 11, 2020
Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodellingKieran F Docherty, Ross T Campbell, Katriona J M Brooksbank, et al.
Pageof 56

Showing results (291-300 of 557) with videos related to

Sort By:
Pageof 56
European Heart Journal|January 29, 2024
A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy RegistryAlice M Jackson, Sorel Goland, Hasan Ali Farhan, et al.
The Lancet. Healthy Longevity|September 21, 2023
Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide studyMariam Elmegaard Malik, Jawad Haider Butt, Jarl Emanuel Strange, et al.
European Heart Journal|April 17, 2008
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programmeMichael R MacDonald, Mark C Petrie, Fumi Varyani, et al.
European Heart Journal|March 6, 2025
Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysisMatthew Ryan, Mark C Petrie, Evangelos Kontopantelis, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 21, 2020
Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysisMario Gaudino, Irbaz Hameed, Faiza M Khan, et al.
Journal of the American Heart Association|September 29, 2022
Adherence and Discontinuation of Optimal Heart Failure Therapies According to Age: A Danish Nationwide StudyCaroline H Garred, Deewa Zahir, Jawad H Butt, et al.
Lancet (London, England)|March 31, 2016
A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trialGerd Hasenfuß, Chris Hayward, Dan Burkhoff, et al.
Heart (British Cardiac Society)|August 10, 2016
Infarct size and left ventricular remodelling after preventive percutaneous coronary interventionKenneth Mangion, David Carrick, Barry W Hennigan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 4, 2020
Thermodilution-derived temperature recovery time: a novel predictor of microvascular reperfusion and prognosis after myocardial infarctionAnnette M Maznyczka, David Carrick, Keith G Oldroyd, et al.
ESC Heart Failure|December 11, 2020
Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodellingKieran F Docherty, Ross T Campbell, Katriona J M Brooksbank, et al.
Pageof 56